Characteristics of subjective cognitive decline associated with amyloid positivity

O. Janssen; W.J. Jansen; S.J.B. Vos; M. Boada; L. Parnetti; T. Gabryelewicz; T. Fladby; J.L. Molinuevo; S. Villeneuve; J. Hort; S. Epelbaum; A. Lleo; S. Engelborghs; W.M. van der Flier; S. Landau; J. Popp; A. Wallin; P. Scheltens; M.O. Rikkert; P.J. Snyder; C. Rowe; G. Chetelat; A. Ruiz; M. Marquie; E. Chipi; S. Wolfsgruber; M. Heneka; H. Boecker; O. Peters; J. Jarholm; L. Rami; A. Tort-Merino; A.P. Binette; J. Poirier; P. Rosa-Neto; J. Cerman; B. Dubois; M. Teichmann; D. Alcolea; J. Fortea; M.B. Sanchez-Saudinos; J. Ebenau; C. Pocnet; M. Eckerstrom; L. Thompson; V. Villemagne; R. Buckley; S. Burnham; M. Delarue; Y. Freund-Levi; Alzheimer's Disease Neuroimaging Initiative; FACEHBI study group; PREVENT-AD research group

doi:10.1002/alz.12512

Characteristics of subjective cognitive decline associated with amyloid positivity

O. Janssen^*, W.J. Jansen, S.J.B. Vos, M. Boada, L. Parnetti, T. Gabryelewicz, T. Fladby, J.L. Molinuevo, S. Villeneuve, J. Hort, S. Epelbaum, A. Lleo, S. Engelborghs, W.M. van der Flier, S. Landau, J. Popp, A. Wallin, P. Scheltens, M.O. Rikkert, P.J. SnyderC. Rowe, G. Chetelat, A. Ruiz, M. Marquie, E. Chipi, S. Wolfsgruber, M. Heneka, H. Boecker, O. Peters, J. Jarholm, L. Rami, A. Tort-Merino, A.P. Binette, J. Poirier, P. Rosa-Neto, J. Cerman, B. Dubois, M. Teichmann, D. Alcolea, J. Fortea, M.B. Sanchez-Saudinos, J. Ebenau, C. Pocnet, M. Eckerstrom, L. Thompson, V. Villemagne, R. Buckley, S. Burnham, M. Delarue, Y. Freund-Levi, Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group, PREVENT-AD research group

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Number of pages	14
Journal	Alzheimer's & Dementia
DOIs	https://doi.org/10.1002/alz.12512
Publication status	E-pub ahead of print - 8 Dec 2021

Keywords

Alzheimer's disease
amyloid
cerebrospinal fluid
positron emission tomography
subjective cognitive decline
PRECLINICAL ALZHEIMERS-DISEASE
MEMORY COMPLAINTS
OLDER-ADULTS
DEMENTIA
POPULATION
RISK
COMMUNITY
PREVALENCE
DEPOSITION
SYMPTOMS

Access to Document

10.1002/alz.12512Licence: CC BY-NC

Cite this

Janssen, O., Jansen, W. J., Vos, S. J. B., Boada, M., Parnetti, L., Gabryelewicz, T., Fladby, T., Molinuevo, J. L., Villeneuve, S., Hort, J., Epelbaum, S., Lleo, A., Engelborghs, S., van der Flier, W. M., Landau, S., Popp, J., Wallin, A., Scheltens, P., Rikkert, M. O., ... PREVENT-AD research group (2021). Characteristics of subjective cognitive decline associated with amyloid positivity. Alzheimer's & Dementia. https://doi.org/10.1002/alz.12512

Janssen, O. ; Jansen, W.J. ; Vos, S.J.B. ; Boada, M. ; Parnetti, L. ; Gabryelewicz, T. ; Fladby, T. ; Molinuevo, J.L. ; Villeneuve, S. ; Hort, J. ; Epelbaum, S. ; Lleo, A. ; Engelborghs, S. ; van der Flier, W.M. ; Landau, S. ; Popp, J. ; Wallin, A. ; Scheltens, P. ; Rikkert, M.O. ; Snyder, P.J. ; Rowe, C. ; Chetelat, G. ; Ruiz, A. ; Marquie, M. ; Chipi, E. ; Wolfsgruber, S. ; Heneka, M. ; Boecker, H. ; Peters, O. ; Jarholm, J. ; Rami, L. ; Tort-Merino, A. ; Binette, A.P. ; Poirier, J. ; Rosa-Neto, P. ; Cerman, J. ; Dubois, B. ; Teichmann, M. ; Alcolea, D. ; Fortea, J. ; Sanchez-Saudinos, M.B. ; Ebenau, J. ; Pocnet, C. ; Eckerstrom, M. ; Thompson, L. ; Villemagne, V. ; Buckley, R. ; Burnham, S. ; Delarue, M. ; Freund-Levi, Y. ; Alzheimer's Disease Neuroimaging Initiative ; FACEHBI study group ; PREVENT-AD research group. / Characteristics of subjective cognitive decline associated with amyloid positivity. In: Alzheimer's & Dementia. 2021.

@article{5743023385b04c808a70dadc55b29a1c,

title = "Characteristics of subjective cognitive decline associated with amyloid positivity",

keywords = "Alzheimer's disease, amyloid, cerebrospinal fluid, positron emission tomography, subjective cognitive decline, PRECLINICAL ALZHEIMERS-DISEASE, MEMORY COMPLAINTS, OLDER-ADULTS, DEMENTIA, POPULATION, RISK, COMMUNITY, PREVALENCE, DEPOSITION, SYMPTOMS",

author = "O. Janssen and W.J. Jansen and S.J.B. Vos and M. Boada and L. Parnetti and T. Gabryelewicz and T. Fladby and J.L. Molinuevo and S. Villeneuve and J. Hort and S. Epelbaum and A. Lleo and S. Engelborghs and {van der Flier}, W.M. and S. Landau and J. Popp and A. Wallin and P. Scheltens and M.O. Rikkert and P.J. Snyder and C. Rowe and G. Chetelat and A. Ruiz and M. Marquie and E. Chipi and S. Wolfsgruber and M. Heneka and H. Boecker and O. Peters and J. Jarholm and L. Rami and A. Tort-Merino and A.P. Binette and J. Poirier and P. Rosa-Neto and J. Cerman and B. Dubois and M. Teichmann and D. Alcolea and J. Fortea and M.B. Sanchez-Saudinos and J. Ebenau and C. Pocnet and M. Eckerstrom and L. Thompson and V. Villemagne and R. Buckley and S. Burnham and M. Delarue and Y. Freund-Levi and {Alzheimer's Disease Neuroimaging Initiative} and {FACEHBI study group} and {PREVENT-AD research group}",

year = "2021",

month = dec,

day = "8",

doi = "10.1002/alz.12512",

language = "English",

journal = "Alzheimer's & Dementia",

issn = "1552-5260",

publisher = "Elsevier Science",

}

Janssen, O , Jansen, WJ , Vos, SJB, Boada, M, Parnetti, L, Gabryelewicz, T, Fladby, T, Molinuevo, JL, Villeneuve, S, Hort, J, Epelbaum, S, Lleo, A, Engelborghs, S, van der Flier, WM, Landau, S, Popp, J, Wallin, A, Scheltens, P, Rikkert, MO, Snyder, PJ, Rowe, C, Chetelat, G, Ruiz, A, Marquie, M, Chipi, E, Wolfsgruber, S, Heneka, M, Boecker, H, Peters, O, Jarholm, J, Rami, L, Tort-Merino, A, Binette, AP, Poirier, J, Rosa-Neto, P, Cerman, J, Dubois, B, Teichmann, M, Alcolea, D, Fortea, J, Sanchez-Saudinos, MB, Ebenau, J, Pocnet, C, Eckerstrom, M, Thompson, L, Villemagne, V, Buckley, R, Burnham, S, Delarue, M, Freund-Levi, Y, Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group & PREVENT-AD research group 2021, 'Characteristics of subjective cognitive decline associated with amyloid positivity', Alzheimer's & Dementia. https://doi.org/10.1002/alz.12512

Characteristics of subjective cognitive decline associated with amyloid positivity. / Janssen, O.; Jansen, W.J.; Vos, S.J.B.; Boada, M.; Parnetti, L.; Gabryelewicz, T.; Fladby, T.; Molinuevo, J.L.; Villeneuve, S.; Hort, J.; Epelbaum, S.; Lleo, A.; Engelborghs, S.; van der Flier, W.M.; Landau, S.; Popp, J.; Wallin, A.; Scheltens, P.; Rikkert, M.O.; Snyder, P.J.; Rowe, C.; Chetelat, G.; Ruiz, A.; Marquie, M.; Chipi, E.; Wolfsgruber, S.; Heneka, M.; Boecker, H.; Peters, O.; Jarholm, J.; Rami, L.; Tort-Merino, A.; Binette, A.P.; Poirier, J.; Rosa-Neto, P.; Cerman, J.; Dubois, B.; Teichmann, M.; Alcolea, D.; Fortea, J.; Sanchez-Saudinos, M.B.; Ebenau, J.; Pocnet, C.; Eckerstrom, M.; Thompson, L.; Villemagne, V.; Buckley, R.; Burnham, S.; Delarue, M.; Freund-Levi, Y.; Alzheimer's Disease Neuroimaging Initiative; FACEHBI study group; PREVENT-AD research group.

In: Alzheimer's & Dementia, 08.12.2021.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Characteristics of subjective cognitive decline associated with amyloid positivity

AU - Janssen, O.

AU - Jansen, W.J.

AU - Vos, S.J.B.

AU - Boada, M.

AU - Parnetti, L.

AU - Gabryelewicz, T.

AU - Fladby, T.

AU - Molinuevo, J.L.

AU - Villeneuve, S.

AU - Hort, J.

AU - Epelbaum, S.

AU - Lleo, A.

AU - Engelborghs, S.

AU - van der Flier, W.M.

AU - Landau, S.

AU - Popp, J.

AU - Wallin, A.

AU - Scheltens, P.

AU - Rikkert, M.O.

AU - Snyder, P.J.

AU - Rowe, C.

AU - Chetelat, G.

AU - Ruiz, A.

AU - Marquie, M.

AU - Chipi, E.

AU - Wolfsgruber, S.

AU - Heneka, M.

AU - Boecker, H.

AU - Peters, O.

AU - Jarholm, J.

AU - Rami, L.

AU - Tort-Merino, A.

AU - Binette, A.P.

AU - Poirier, J.

AU - Rosa-Neto, P.

AU - Cerman, J.

AU - Dubois, B.

AU - Teichmann, M.

AU - Alcolea, D.

AU - Fortea, J.

AU - Sanchez-Saudinos, M.B.

AU - Ebenau, J.

AU - Pocnet, C.

AU - Eckerstrom, M.

AU - Thompson, L.

AU - Villemagne, V.

AU - Buckley, R.

AU - Burnham, S.

AU - Delarue, M.

AU - Freund-Levi, Y.

AU - Alzheimer's Disease Neuroimaging Initiative

AU - FACEHBI study group

AU - PREVENT-AD research group

PY - 2021/12/8

Y1 - 2021/12/8

KW - Alzheimer's disease

KW - amyloid

KW - cerebrospinal fluid

KW - positron emission tomography

KW - subjective cognitive decline

KW - PRECLINICAL ALZHEIMERS-DISEASE

KW - MEMORY COMPLAINTS

KW - OLDER-ADULTS

KW - DEMENTIA

KW - POPULATION

KW - RISK

KW - COMMUNITY

KW - PREVALENCE

KW - DEPOSITION

KW - SYMPTOMS

U2 - 10.1002/alz.12512

DO - 10.1002/alz.12512

M3 - Article

JO - Alzheimer's & Dementia

JF - Alzheimer's & Dementia

SN - 1552-5260

ER -